Kewaunee Scientific Corporation (KEQU)
NASDAQ: KEQU · Real-Time Price · USD
36.31
-1.36 (-3.61%)
Sep 2, 2026, 4:00 PM EDT - Market closed

Kewaunee Scientific Income Statement

Millions USD. Fiscal year is May - Apr.
Fiscal Year
FY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Apr '26 Apr '25 Apr '24 Apr '23 Apr '22
282240.47203.76219.49168.87
Revenue Growth
17.27%18.02%-7.17%29.98%14.51%
Cost of Revenue
201.56171.62151.7183.91144.65
Gross Profit
80.4468.8652.0535.5924.22
Selling, General & Admin
63.7351.133.9330.326.45
Operating Expenses
63.7351.133.9330.326.45
Operating Income
16.7217.7618.125.29-2.23
Interest Expense
-3.86-3.21-1.8-1.73-0.63
Other Non Operating Income (Expenses)
0.880.240.810.940.4
EBT Excluding Unusual Items
13.7314.7917.144.5-2.46
Merger & Restructuring Charges
-----0.03
Other Unusual Items
---4.02--
Pretax Income
13.7314.7913.124.5-2.49
Income Tax Expense
3.273.2-5.943.143.52
Earnings From Continuing Operations
10.4711.5819.061.36-6
Minority Interest in Earnings
-0.85-0.18-0.3-0.62-0.12
Net Income
9.6211.4118.750.74-6.13
Net Income to Common
9.6211.4118.750.74-6.13
Net Income Growth
-15.67%-39.18%2441.06%--
Shares Outstanding (Basic)
33333
Shares Outstanding (Diluted)
33333
Shares Change
0.13%1.40%1.24%4.16%0.94%
EPS (Basic)
3.363.986.510.26-2.20
EPS (Diluted)
3.223.836.380.25-2.20
EPS Growth
-15.93%-39.97%2452.00%--

Additional Metrics

Fiscal Year
FY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Apr '26 Apr '25 Apr '24 Apr '23 Apr '22
Free Cash Flow
14.712.6215.19-7.94-9.79
Free Cash Flow Per Share
4.934.245.17-2.73-3.52
Gross Margin
28.52%28.63%25.55%16.21%14.34%
Operating Margin
5.93%7.38%8.89%2.41%-1.32%
Profit Margin
3.41%4.74%9.20%0.34%-3.63%
Free Cash Flow Margin
5.21%5.25%7.46%-3.62%-5.80%
EBITDA
2322.2421.258.160.54
EBITDA Margin
8.15%9.25%10.43%3.72%0.32%
D&A For EBITDA
6.284.483.132.872.77
EBIT
16.7217.7618.125.29-2.23
EBIT Margin
5.93%7.38%8.89%2.41%-1.32%
Effective Tax Rate
23.80%21.66%-69.79%-
Advertising Expenses
1.50.910.340.230.18
SEC Filings: 10-K · 10-Q